VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
CCRNCross Country Healthcare, Inc.
$13.17$426M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
  1. Home
  2. Financial Ratios

  1. Home
  2. CCRN
  3. Financial Ratios

Cross Country Healthcare, Inc. (CCRN) Financial Ratios

27 years of historical data (1999–2025) · Healthcare · Medical - Care Facilities

View Quarterly Ratios →

P/E Ratio
↑
-4.49
↓-156% vs avg
5yr avg: 8.07
00%ile100
30Y Low5.3·High117.1
View P/E History →
EV/EBITDA
↑
23.96
↓-86% vs avg
5yr avg: 172.45
082%ile100
30Y Low4.1·High41.1
P/FCF
↓
10.62
↑+82% vs avg
5yr avg: 5.84
035%ile100
30Y Low3.4·High159.9
P/B Ratio
↓
1.32
↓-31% vs avg
5yr avg: 1.93
032%ile100
30Y Low0.7·High3.7
ROE
↓
-25.6%
↑-235% vs avg
5yr avg: 18.9%
011%ile100
30Y Low-46%·High58%
Debt/EBITDA
↓
0.17
↓-89% vs avg
5yr avg: 1.64
011%ile100
30Y Low0.0·High6.1

Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.

CCRN Valuation Multiples

Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow

Cross Country Healthcare, Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis. On a free-cash-flow basis, the stock trades at 10.6x P/FCF, 82% above the 5-year average of 5.8x.

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Market Cap$426M$263M$606M$803M$997M$1.0B$320M$416M$261M$461M$566M
Enterprise Value$319M$156M$528M$791M$1.2B$1.2B$397M$510M$329M$535M$632M
P/E Ratio →-4.49——11.045.297.86———12.63104.07
P/S Ratio0.400.250.450.400.360.620.380.510.320.530.68
P/B Ratio1.320.811.451.702.183.492.072.551.201.943.73
P/FCF10.626.555.443.427.96—14.17159.9415.9411.4223.95
P/OCF8.835.445.053.237.44—11.7775.0912.4510.1418.77

P/E links to full P/E history page with 30-year chart

CCRN EV Ratios

Enterprise-value multiples — capital-structure-neutral measures of total business value

Cross Country Healthcare, Inc.'s enterprise value stands at 24.0x EBITDA, 86% below its 5-year average of 172.4x. The Healthcare sector median is 14.2x, placing the stock at a 69% premium on an enterprise-value basis.

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
EV / Revenue—0.150.390.390.410.740.470.620.400.620.76
EV / EBITDA23.9611.71832.136.044.088.29964.73——24.4141.14
EV / EBIT———7.134.308.4924.3057.52—62.8419.67
EV / FCF—3.894.743.379.19—17.55196.0320.0313.2526.76

CCRN Profitability

Margins and return-on-capital ratios measuring operating efficiency

Cross Country Healthcare, Inc. earns an operating margin of -0.3%. Operating margins have compressed from 5.6% to -0.3% over the past 3 years, signaling potential cost pressures or competitive headwinds. A negative ROE of -25.6% indicates the company is currently destroying shareholder equity.

Margins

Full margin charts and quarterly trend are on the Earnings History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Gross Margin18.7%18.7%20.4%22.3%22.3%22.4%24.2%24.8%25.7%26.4%26.6%
Operating Margin-0.3%-0.3%-1.3%5.6%9.6%8.3%-1.1%-1.9%-1.6%1.4%0.7%
Net Profit Margin-9.0%-9.0%-1.1%3.6%6.6%7.9%-1.5%-7.0%-2.1%4.3%1.0%

Return on Capital

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
ROE-25.6%-25.6%-3.3%15.6%49.3%58.4%-8.1%-30.2%-7.4%19.3%5.4%
ROA-18.3%-18.3%-2.3%8.9%22.1%24.2%-3.5%-14.3%-3.8%8.8%2.1%
ROIC-0.9%-0.9%-3.2%15.8%36.7%28.9%-2.8%-4.3%-3.2%3.3%2.1%
ROCE-0.8%-0.8%-3.4%18.7%44.6%35.0%-3.3%-4.9%-3.6%3.5%2.2%

CCRN Leverage & Debt

Solvency and debt-coverage ratios — lower is generally safer

Cross Country Healthcare, Inc. carries a Debt/EBITDA ratio of 0.2x, which is very conservative (95% below the sector average of 3.2x). The company holds a net cash position — cash of $109M exceeds total debt of $2M, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns.

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Debt / Equity0.010.010.010.010.350.660.500.580.380.420.57
Debt / EBITDA0.170.176.100.040.561.31189.79——4.525.66
Net Debt / Equity—-0.33-0.19-0.020.340.650.490.570.310.310.44
Net Debt / EBITDA-7.98-7.98-122.46-0.090.551.31185.89——3.364.32
Debt / FCF—-2.65-0.70-0.051.23—3.3836.084.101.822.81
Interest Coverage-1.56-1.56-0.3313.7118.5921.135.651.67-2.222.025.26

Net cash position: cash ($109M) exceeds total debt ($2M)

CCRN Liquidity & Efficiency

Short-term solvency ratios and asset-utilisation metrics

Cross Country Healthcare, Inc.'s current ratio of 3.78x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The current ratio has improved from 2.79x to 3.78x over the past 3 years.

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Current Ratio3.783.782.782.792.492.541.962.152.282.212.12
Quick Ratio3.783.782.782.792.452.541.962.152.212.152.05
Cash Ratio1.401.400.680.120.010.010.020.010.190.270.21
Asset Turnover—2.352.282.972.962.292.342.151.911.852.15
Inventory Turnover————196.88———97.76120.3899.87
Days Sales Outstanding—57.9965.9670.1885.93108.6276.2477.4876.1474.7377.36

CCRN Shareholder Yields

Earnings, FCF, buyback, and dividend yields — total returns to shareholders

Cross Country Healthcare, Inc. returns 1.6% to shareholders annually primarily through share buybacks.

Dividends

Full dividend history and growth charts are on the Dividend History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Dividend Yield———————————
Payout Ratio———————————

Total Shareholder Return Metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Earnings Yield———9.1%18.9%12.7%———7.9%1.0%
FCF Yield9.4%15.3%18.4%29.2%12.6%—7.1%0.6%6.3%8.8%4.2%
Buyback Yield1.6%2.6%6.2%7.2%3.5%0.2%0.2%0.2%1.9%0.4%0.0%
Total Shareholder Yield1.6%2.6%6.2%7.2%3.5%0.2%0.2%0.2%1.9%0.4%0.0%
Shares Outstanding—$32M$33M$35M$38M$37M$36M$36M$36M$36M$36M

Peer Comparison

Compare CCRN with 10 similar companies in its peer group

CompanyMarket CapP/EEV/EBITDAP/FCFGross MarginOp MarginROEROICDebt/EBITDA
CCRN logoCCRNYou$426M-4.524.010.618.7%-0.3%-25.6%-0.9%0.2
AMN logoAMN$1B-12.510.45.128.3%1.2%-14.2%1.6%4.2
TBI logoTBI$203M-4.2170.2—21.2%-1.7%-16.3%-5.2%83.1
HCSG logoHCSG$2B28.323.111.813.0%2.6%11.7%9.0%0.4
KELYA logoKELYA$394M-1.6—3.520.1%-1.6%-23.0%-4.0%—
MAN logoMAN$2B-115.79.5—16.7%1.3%-0.6%5.6%7.4
ASGN logoASGN$895M8.15.33.127.2%6.5%6.3%6.9%3.2
KFY logoKFY$4B15.57.612.388.6%12.6%13.6%18.6%1.3
HIMS logoHIMS$8B69.555.1105.373.8%4.5%25.2%8.6%7.9
PINC logoPINC$2B128.521.37.373.4%0.1%1.2%0.0%2.4
TDOC logoTDOC$1B-7.117.15.169.5%-10.4%-13.9%-11.5%10.4
Healthcare Median—22.114.218.563.9%-4.3%-32.6%-11.6%3.2

Peer selection based on competitive and market overlap. Compare multiple stocks →

Download Financial Ratios Data

Includes 30+ ratios · 27 years · Updated daily

Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

CCRN — Frequently Asked Questions

Quick answers to the most common questions about buying CCRN stock.

What is Cross Country Healthcare, Inc.'s P/E ratio?

Cross Country Healthcare, Inc.'s current P/E ratio is -4.5x. The historical average is 39.2x.

What is Cross Country Healthcare, Inc.'s EV/EBITDA?

Cross Country Healthcare, Inc.'s current EV/EBITDA is 24.0x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 15.0x.

What is Cross Country Healthcare, Inc.'s ROE?

Cross Country Healthcare, Inc.'s return on equity (ROE) is -25.6%. The historical average is 1.3%.

Is CCRN stock overvalued?

Based on historical data, Cross Country Healthcare, Inc. is trading at a P/E of -4.5x. Compare with industry peers and growth rates for a complete picture.

What are Cross Country Healthcare, Inc.'s profit margins?

Cross Country Healthcare, Inc. has 18.7% gross margin and -0.3% operating margin.

How much debt does Cross Country Healthcare, Inc. have?

Cross Country Healthcare, Inc.'s Debt/EBITDA ratio is 0.2x, indicating low leverage. A ratio below 2x is generally considered financially healthy.